Table 1 Demographics and clinical information

From: Magnetic seizure therapy reduces suicidal ideation and produces neuroplasticity in treatment-resistant depression

Category

Value

Sample size

23

Sex, no. (%)

 Male

11 (49)

 Female

12 (51)

Age, mean (SD), years

45.0 (12.2)

Illness duration, mean (SD), years

20.7 (15.0)

No. of depressive episodes, mean (SD)a

8.3 (11.3)

ATHF (cumulative score for current episode), mean (SD)

11.6 (7.6)

Medication, n: dose (mg)

Antidepressant:

Bupropion, 5: (300, 300, 300, 300, 450)

Duloxetine, 4: (120, 60, 120, 120)

Trazodone, 4: (50, 100, 50, 100)

Desvenlafaxine, 3: (50, 150, 100)

Escitalopram, 3: (40, 20, 35)

Quetiapine, 3: (50, 300, 150)

Fluoxetine, 2: (120, 60)

Sertraline, 2: (100, 100)

Mirtazapine, 1: (45)

Nortriptyline, 1: (75)

Venlafaxine, 1: (225)

Antipsychotic:

Aripiprazole, 2: (300, 10)

Risperidone, 2: (2, 4)

Benzodiazepine:

Clonazepam, 5: (0.25, 1, 1, 0.5, 1)

Lorazepam, 4: (1, 1.5, 0.5, 0.5)

Zopiclone, 2: (7.5, 7.5)

Diazepam, 1: (20)

Others:

Lithium, 1: (450)

Pregabalin, 1: (150)

  1. aInformation was only available from 13 patients, 9 had too many episodes to keep track, and 1 patient had indeterminate number of episodes.
Back to article page